Dublin, Sept. 21, 2020 (GLOBE NEWSWIRE) -- The "Global CRISPR & Cas Genes Market Size, Share & Trends Analysis by Product & Service (Vector-based Cas, DNA-free Cas, Cell Line Engineering), Application, End Use, and Segment Forecasts 2020-2027" report has been added to ResearchAndMarkets.com's offering.
The global clustered regularly interspaced short palindromic repeats (CRISPR) and CRISPR-associated (Cas) genes market size is expected to reach USD 4.88 billion by 2027, expanding at a CAGR of 16.6% from 2020 to 2027.
CRISPR & Cas Genes Market Report Highlights
The product segment is anticipated to dominate the market throughout the forecast period. This is attributed to the presence of enhanced individual products that can serve multiple purposes including genome engineering, specific genome cleavage using gRNAs, easy gene knockouts, along with reduced off-target cutting, and increased specificity
Cell line engineering services accounted for the largest market share in 2019. The development of this technology has simplified the genome engineering process to a large extent
In biomedical applications, genome engineering held the largest revenue share in 2019 as a result of an increase in the adoption of genome editing techniques for modifications in germline and therapeutics development
Recent advancements in CRISPR/Cas genome editing allow targeted modification in crops, thereby promising crop improvement and revenue generation in the market
A significant number of research studies carried out to develop disease-specific novel therapies and the presence of a huge clinical pipeline that integrates the application of this gene-editing technology are expected to boost revenue generation for the biotechnology and pharmaceutical companies segment
Asia Pacific is anticipated to witness the fastest growth over the forecast period. China holds a significant position in the CRISPR market and is increasingly exploring genome-editing for the development of medicines. The country has launched several CRISPER-based clinical trials, especially for cancer treatment.
Rise in the adoption of CRISPR technology in epigenetics, therapeutics, human germline editing, plant genome editing, and other fields of biotechnology is expected to drive the market.
Presence of a large number of service providers that provide knockout, knock-in, gene repression, gene activation, and other cell line engineering services propel the growth of cell line engineering services. In biomedical applications, genome engineering held the largest revenue share in 2019. Adoption of gene editing techniques for human- and non-human-based genomic engineering is one of the key factors that drive the segment.
The molecular scissor can facilitate the detection of viruses, allowing the development of cost-effective, robust, and rapid point-of-care diagnostics. It allows the detection of viruses at a level of molecular concentration that researchers rarely assess. Sherlock Bioscience estimated that a CRISPR-powered diagnostic test would be available in the future at a reasonable price. In recent times, the most important innovation has been the development of a test for COVID-19.
In March 2020, Mesa Biotech announced FDA authorization for its Accula device, a hand-held COVID-19 diagnostic test. Similarly, in April 2020, CSIR lab announced the development of a paper-strip test for Covid-19 that uses CRISPR-Cas9 to target and identifies the genomic sequences of the virus. Unlike the PCR tests, this test is available at a very low price, USD 6.59 (INR 1 = USD 0.013). Therefore, such initiatives are expected to encourage other players to leverage this crisis and launch novel products.
Key Topics Covered:
Story continues
Chapter 1 Research Methodology
Chapter 2 Executive Summary2.1 Market Snapshot, 2019 (USD Million)
Chapter 3 Crispr And Cas Genes Market Variables, Trends & Scope3.1 Market Trends & Outlook3.2 Market Segmentation & Scope3.3 Market Lineage Outlook3.3.1 Parent Market Outlook3.3.2 Related/Ancillary Market Outlook3.4 Crispr And Cas Genes: Patent Landscape3.4.1 By End - Use Settings3.4.2 By Variants Of Crispr Enzymes3.5 Penetration And Growth Prospect Mapping, By Biomedical Applications, 20193.6 Potential Threat Analysis To Crispr Technology3.6.1 Variations In The Crispr System3.7 Investors Perspective Analysis3.8 User Perspective Analysis3.9 Technology Mapping In Crispr Genome Editing Workflow3.10 Developments And Innovations For Analysis Of Off - Target Effects3.11 Crispr Technologies: Clinical Penetration3.11.1 Human Therapeutics3.11.2 Diagnostics3.11.3 Microbiome Research And Drug Resistance3.11.4 Animal Disease Models
Chapter 4 Industry Outlook4.1 Market Dynamics4.1.1 Market Driver Analysis4.1.1.1 Rising Adoption In Diverse Fields Of Biotechnology4.1.1.1.1 Epigenetics4.1.1.1.2 Medicine4.1.1.1.3 Human Germline Editing4.1.1.1.4 Tool For Qualitative And Quantitative Plant Genome Editing4.1.1.2 Technological Advancements In Crispr4.1.1.3 Introduction Of Anti - Crispr Protein4.1.1.4 Ongoing Competition For Crispr Commercialization4.1.2 Market Restraint Analysis4.1.2.1 Off - Target Effects Of Crispr Technology4.1.2.2 Intellectual Property Disputes Pertaining To Cas4.1.2.3 Ethical Concerns And Implications With Respect To Human Genome Editing4.1.3 Market Opportunity Analysis4.1.3.1 Expanding Gene & Cell Therapy Area4.1.3.2 Government Fund In Genomic R&D4.1.4 Market Challenge Analysis4.1.4.1 Risks Pertaining To The Usage Of Genetically Modified Food4.2 Policy Making & Regulation For Genetic Modification Using Crispr4.3 Porter's Five Forces Analysis4.4 SWOT Analysis, By Factor (Political & Legal, Economic, And Technological)
Chapter 5 Competitive Landscape5.1 Companies (Diagnostic & Drug Developers) Leveraging Gene Editing Technologies5.2 Major Deals & Strategic Alliances Analysis5.3 Market Entry Strategies5.3.1 Crispr Therapeutics: Business Translation5.3.2 Crispr Gene Editing Companies' Toolboxes5.4 Crispr And Cas Genes Market: Pipeline Analysis5.4.1 Editas Medicine5.4.2 Intellia Therapeutics, Inc.5.4.3 Crispr Therapeutics5.4.4 Caribou Biosciences, Inc.5.4.5 Egenesis5.4.6 Beam Therapeutics5.4.7 Ksq Therapeutics5.4.8 Cibus
Chapter 6 Product & Service Business Analysis6.1 Crispr And Cas Genes Market: Product & Service Movement Analysis6.2 By Product6.2.1 Global Crispr And Cas Genes Products Market, 2016 - 2027 (USD Million)6.2.2 Kits & Enzymes6.2.3 Global Crispr And Cas Genes Kits And Enzymes Market, 2016 - 2027 (USD Million)6.2.3.1 Vector - Based Cas96.2.3.2 Dna - Free Cas96.2.4 Libraries6.2.5 Design Tools6.2.6 Antibodies6.2.7 Others6.3 By Service6.3.1 Global Crispr And Cas Genes Service Market, 2016 - 2027 (USD Million)6.3.2 Cell Line Engineering6.3.3 Grna Design6.3.4 Microbial Gene Editing6.3.5 Dna Synthesis
Chapter 7 Application Business Analysis7.1 Crispr And Cas Genes Market: Application Movement Analysis7.2 Biomedical7.2.1 Global Crispr And Cas Genes Market For Biomedical, 2016 - 2027 (USD Million)7.2.2 Genome Engineering7.2.3 Disease Model Studies7.2.4 Functional Genomics7.2.5 Epigenetics7.2.6 Others7.3 Agriculture
Chapter 8 End - Use Business Analysis8.1 Crispr And Cas Genes Market: End - Use Movement Analysis8.1.1 Biotechnology & Pharmaceutical Companies8.1.2 Academics & Government Research Institutes8.1.3 Contract Research Organizations (Cros)
Chapter 9 Regional Business Analysis
Chapter 10 Company Profiles
Astrazeneca
Addgene
Caribou Biosciences, Inc.
Cellectis
Crispr Therapeutics
Editas Medicine, Inc.
Egenesis
F. Hoffmann - La Roche Ltd.
Horizon Discovery Group Plc
Genscript
Danaher Corporation
Intellia Therapeutics, Inc.
Lonza
Merck Kgaa
New England Biolabs
Takara Bio, Inc.
Thermo Fisher Scientific, Inc.
Synthego
Mammoth Biosciences
Inscripta, Inc.
Cibus
Beam Therapeutics
PlanteditVertex Pharmaceuticals Incorporated
Hera Biolabs
Origene Technologies, Inc.
Recombinetics, Inc.
For more information about this report visit https://www.researchandmarkets.com/r/lypwvp
About ResearchAndMarkets.comResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
Go here to see the original:
Global $4.88 Bn CRISPR & Cas Genes Market to 2027: Opportunities in the Expanding Gene & Cell Therapy Area & Government Fund In Genomic R&D - Yahoo...
Recommendation and review posted by G. Smith
